Literature DB >> 21464132

Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration.

Roxana A Radu1, Jane Hu, Quan Yuan, Darcy L Welch, Jacob Makshanoff, Marcia Lloyd, Stephen McMullen, Gabriel H Travis, Dean Bok.   

Abstract

Accumulation of vitamin A-derived lipofuscin fluorophores in the retinal pigment epithelium (RPE) is a pathologic feature of recessive Stargardt macular dystrophy, a blinding disease caused by dysfunction or loss of the ABCA4 transporter in rods and cones. Age-related macular degeneration, a prevalent blinding disease of the elderly, is strongly associated with mutations in the genes for complement regulatory proteins (CRP), causing chronic inflammation of the RPE. Here we explore the possible relationship between lipofuscin accumulation and complement activation in vivo. Using the abca4(-/-) mouse model for recessive Stargardt, we investigated the role of lipofuscin fluorophores (A2E-lipofuscin) on oxidative stress and complement activation. We observed higher expression of oxidative-stress genes and elevated products of lipid peroxidation in eyes from abca4(-/-) versus wild-type mice. We also observed higher levels of complement-activation products in abca4(-/-) RPE cells. Unexpectedly, expression of multiple CRPs, which protect cells from attack by the complement system, were lower in abca4(-/-) versus wild-type RPE. To test whether acute exposure of healthy RPE cells to A2E-lipofuscin affects oxidative stress and expression of CRPs, we fed cultured fetal-derived human RPE cells with rod outer segments from wild-type or abca4(-/-) retinas. In contrast to RPE cells in abca4(-/-) mice, human RPE cells exposed to abca4(-/-) rod outer segments adaptively increased expression of both oxidative-stress and CRP genes. These results suggest that A2E accumulation causes oxidative stress, complement activation, and down-regulation of protective CRP in the Stargardt mouse model. Thus, Stargardt disease and age-related macular degeneration may both be caused by chronic inflammation of the RPE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21464132      PMCID: PMC3099675          DOI: 10.1074/jbc.M110.191866

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Observation of A2E oxidation products in human retinal lipofuscin.

Authors:  L B Avalle; Z Wang; J P Dillon; E R Gaillard
Journal:  Exp Eye Res       Date:  2004-04       Impact factor: 3.467

2.  Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration.

Authors:  N L Mata; J Weng; G H Travis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

3.  A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers.

Authors:  J Hu; D Bok
Journal:  Mol Vis       Date:  2001-02-07       Impact factor: 2.367

4.  Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE.

Authors:  Janet R Sparrow; Jilin Zhou; Shimon Ben-Shabat; Heidi Vollmer; Yasuhiro Itagaki; Koji Nakanishi
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

Review 5.  The role of oxidative stress in the pathogenesis of age-related macular degeneration.

Authors:  S Beatty; H Koh; M Phil; D Henson; M Boulton
Journal:  Surv Ophthalmol       Date:  2000 Sep-Oct       Impact factor: 6.048

6.  Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid.

Authors:  P T Johnson; K E Betts; M J Radeke; G S Hageman; D H Anderson; L V Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-01       Impact factor: 11.205

7.  An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice.

Authors:  Jayakrishna Ambati; Akshay Anand; Stefan Fernandez; Eiji Sakurai; Bert C Lynn; William A Kuziel; Barrett J Rollins; Balamurali K Ambati
Journal:  Nat Med       Date:  2003-10-19       Impact factor: 53.440

8.  Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration.

Authors:  Xiaorong Gu; Susan Gillette Meer; Masaru Miyagi; Mary E Rayborn; Joe G Hollyfield; John W Crabb; Robert G Salomon
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

9.  Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence.

Authors:  Artur V Cideciyan; Tomas S Aleman; Malgorzata Swider; Sharon B Schwartz; Janet D Steinberg; Alexander J Brucker; Albert M Maguire; Jean Bennett; Edwin M Stone; Samuel G Jacobson
Journal:  Hum Mol Genet       Date:  2004-01-06       Impact factor: 6.150

Review 10.  The dynamic nature of Bruch's membrane.

Authors:  J C Booij; D C Baas; J Beisekeeva; T G M F Gorgels; A A B Bergen
Journal:  Prog Retin Eye Res       Date:  2009-09-10       Impact factor: 21.198

View more
  72 in total

Review 1.  Complement dysregulation in AMD: RPE-Bruch's membrane-choroid.

Authors:  Janet R Sparrow; Keiko Ueda; Jilin Zhou
Journal:  Mol Aspects Med       Date:  2012-04-05

2.  Leukemia inhibitory factor coordinates the down-regulation of the visual cycle in the retina and retinal-pigmented epithelium.

Authors:  Ana J Chucair-Elliott; Michael H Elliott; Jiangang Wang; Gennadiy P Moiseyev; Jian-Xing Ma; Luis E Politi; Nora P Rotstein; Shizuo Akira; Satoshi Uematsu; John D Ash
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

3.  Protective responses to sublytic complement in the retinal pigment epithelium.

Authors:  Li Xuan Tan; Kimberly A Toops; Aparna Lakkaraju
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

4.  Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.

Authors:  Konstantin Petrukhin
Journal:  Drug Discov Today Ther Strateg       Date:  2013

5.  Understanding RPE lipofuscin.

Authors:  Janet R Sparrow; John E Dowling; Dean Bok
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-19       Impact factor: 4.799

6.  Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.

Authors:  Alejandra Bosco; Sarah R Anderson; Kevin T Breen; Cesar O Romero; Michael R Steele; Vince A Chiodo; Sanford L Boye; William W Hauswirth; Stephen Tomlinson; Monica L Vetter
Journal:  Mol Ther       Date:  2018-08-24       Impact factor: 11.454

7.  Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degeneration.

Authors:  Haoyu Mao; Soo Jung Seo; Manas R Biswal; Hong Li; Mandy Conners; Arathi Nandyala; Kyle Jones; Yun-Zheng Le; Alfred S Lewin
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-01       Impact factor: 4.799

8.  Correlation of Outer Retinal Degeneration and Choriocapillaris Loss in Stargardt Disease Using En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography.

Authors:  Talal Alabduljalil; Rachel C Patel; Abdullah A Alqahtani; Simon S Gao; Michael J Gale; Miao Zhang; Yali Jia; David Huang; Pei-Wen Chiang; Rui Chen; Jun Wang; Richard G Weleber; Mark E Pennesi; Paul Yang
Journal:  Am J Ophthalmol       Date:  2019-02-14       Impact factor: 5.258

Review 9.  Bisretinoid Photodegradation Is Likely Not a Good Thing.

Authors:  Keiko Ueda; Hye Jin Kim; Jin Zhao; Janet R Sparrow
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

10.  Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype.

Authors:  Roxana A Radu; Jane Hu; Zhichun Jiang; Dean Bok
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.